-
Solutions
-
Vaccine Type
- Live Attenuated and Killed Vaccines
- Subunit Vaccines
- Hapten Conjugate Vaccines
- Totally Synthetic Vaccines
- DNA and RNA Vaccines
- Viral Vector Vaccines
- Bacterial Vector Vaccines
- Virus-Like Particles Based Vaccines
- Cell Based Vaccines
- Plant-based Vaccines
- Bacterial Vaccines
- Viral Vaccines
- Fungal Vaccines
- Parasitic Vaccines
- HBV Vaccines
- HPV Vaccines
- Diabetes Mellitus Vaccines
- Autoimmune Disease Vaccines
- Neurodegenerative Disease Vaccines
- Allergic Diseases Vaccines
- Exosome-based Vaccines
- Universal Vaccines
- Vaccine Design
-
Vaccine Type
-
Services
- Formulation Development
- Vaccine Analytics & Qualification
-
Vaccine GMP Manufacturing
- Diverse Expression System
- Small-Scale Process Development
- Scale-up Development
- GMP Vaccine Production
-
Serum-Free Suspension Culture
- Suspension Culture for Pseudorabies Vaccine Production
- Suspension Culture for PCV2 Vaccine Production
- Suspension Culture for Avian Influenza Vaccine Production
- Suspension Culture for Newcastle Disease Vaccine Production
- Suspension Culture for Porcine Parvovirus Vaccine Production
- Suspension Culture for Rabies Vaccine Production
- Suspension Culture of Insect Cells for Subunit Vaccine Production
- GMP-grade Antigen Production for Vaccine
-
Cancer Vaccines
- Next-CV™ Cancer Vaccine Programs
-
Cancer Vaccine Type
- Personalized Neoantigen Cancer Vaccine
- Tumor Cell Vaccines
- Dendritic Cell Vaccines
- Antigen Vaccines
- Anti-Idiotype Vaccines
- DNA Based Cancer Vaccines
- mRNA Cancer Vaccines
- Vector Based Vaccines
- Fully Synthetic Carbohydrate Based Cancer Vaccines
- BCG Vaccines for Cancer
- Cytomegalovirus-based Cancer Immunotherapy
- Ty21 Based Vaccines for Cancer
- Exosome-based Therapeutic Cancer Vaccines
-
Cancer Vaccine Technology
- Tumor-APC Fusion Technology
- Immune Monitoring Assays
- Cytokine Development to Enhance Antigen Presentation
- The T-win Technology
- Vaccine Combination Immunotherapy
- Biomarker Discovery for Cancer Vaccine
- Microfluidic Cell-squeezing Technology for B Cell-based Vaccine
- Antibody-antigen Fusion Technology for Cancer Vaccine
- MHC Class II-associated li Protein Suppression Technology
- Ag-Fc Fusion Protein Vaccine for Cancer
- Immunological Checkpoint Therapy
- Immunoplacental Therapy Development
- Biomaterial-based Implantable Cancer Vaccine
- Products
- Support
- Contact Us
